2023-08-02

Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting​

2023-02-28

Arbele has entered a joint venture with the Chinese Manufacturers’ Association of Hong Kong (CMA) with a vision to establish accredited cell banking facilities in Hong Kong and Greater Bay Areas

2022-10-24

Arbele CEO Dr. John Luk, attended and presented at the Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship in Washington DC, USA

2022-09-28

嘉立醫療科技於2022年港澳台創新創業大賽榮獲二等獎 / Caleb won 2nd prize at Hong Kong, Macao and Taiwan Innovation and Entrepreneurship Competition 2022

2022-04-11

Arbele has been Inducted in the Hong Kong Tech 300 Angel Fund Program

2022-04-03

Arbele Diagnostic Lab at CMA has Acquired the ISO9001 Accreditation

2021-04-07

Arbele Receives AFCR BRACE Award Investment Funding

2021-03-31

Arbele has Successfully Completed the Incu-Bio Programme of HKSTP

2020-12-04

HKSTP Biotechnology Companies Sanomics and Arbele Enter into a Strategic Partnership to Accelerate Cancer Treatment Development

2020-11-17

CAR-TCR Asia Summit